GRT-6015

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGRT-6015
Drug Alias NameGRT-6015
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 antagonists
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsPsoriasisArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGrunenthal Colombiana Sa
China Registration ClassN/A

Develop Information

Active CompaniesGrunenthal Colombiana Sa
Inactive CompaniesN/A
Active IndicationsPsoriasisArthritis, Psoriatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A